China Medicine Stock Today
| CHME Stock | USD 0.0001 0.00 0.00% |
PerformanceModest
| Odds Of DistressQuite High
|
China Medicine is trading at 1.0E-4 as of the 18th of March 2025, a No Change since the beginning of the trading day. The stock's lowest day price was 1.0E-4. China Medicine has more than 64 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 18th of December 2024 and ending today, the 18th of March 2025. Click here to learn more.
China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China. The company has 23.71 M outstanding shares. More on China Medicine
Moving against China Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
China Pink Sheet Highlights
| Chairman | Senshan Yang |
| Business Concentration | Health Care, Pharmaceuticals, Medical Distribution, Healthcare (View all Sectors) |
China Medicine [CHME] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Nano-Cap' category with a current market capitalization of 284.54 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate China Medicine's market, we take the total number of its shares issued and multiply it by China Medicine's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. China Medicine conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 23.71 M outstanding shares.
China Medicine currently holds about 7.85 M in cash with 16.96 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.2, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check China Medicine Probability Of Bankruptcy
China Medicine Risk Profiles
| Mean Deviation | 7.01 | |||
| Standard Deviation | 31.37 | |||
| Variance | 984.19 | |||
| Risk Adjusted Performance | 0.0662 |
China Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in China Medicine without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
| All Next | Launch Module |
China Medicine Corporate Management
| Minhua Liu | Executive VP and Secretary | Profile | |
| Gavin Chen | Assistant Officer | Profile | |
| Huizhen Yu | Controller | Profile | |
| Ho Fung | Chief Officer | Profile |
Other Information on Investing in China Pink Sheet
China Medicine financial ratios help investors to determine whether China Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Medicine security.